These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 2982371)
1. Specific binding of synthetic human pancreatic growth hormone releasing factor (1-40-OH) to bovine anterior pituitaries. Veliçelebi G; Santacroce TM; Harpold MM Biochem Biophys Res Commun; 1985 Jan; 126(1):33-9. PubMed ID: 2982371 [TBL] [Abstract][Full Text] [Related]
2. Growth hormone-releasing factor binding sites in rat anterior pituitary membrane homogenates: modulation by glucocorticoids. Seifert H; Perrin M; Rivier J; Vale W Endocrinology; 1985 Jul; 117(1):424-6. PubMed ID: 2988927 [TBL] [Abstract][Full Text] [Related]
3. Covalent cross-linking of growth hormone-releasing factor to pituitary receptors. Veliçelebi G; Patthi S; Provow S; Akong M Endocrinology; 1986 Apr; 118(4):1278-83. PubMed ID: 3004907 [TBL] [Abstract][Full Text] [Related]
4. Characterization of [125I-Tyr10]human growth hormone-releasing factor (1-44) amide binding to rat pituitary: evidence for high and low affinity classes of sites. Abribat T; Boulanger L; Gaudreau P Brain Res; 1990 Oct; 528(2):291-9. PubMed ID: 2176911 [TBL] [Abstract][Full Text] [Related]
5. Binding sites for growth hormone releasing factor on rat anterior pituitary cells. Seifert H; Perrin M; Rivier J; Vale W Nature; 1985 Feb 7-13; 313(6002):487-9. PubMed ID: 2982107 [TBL] [Abstract][Full Text] [Related]
6. Somatocrinin receptor coupled with cAMP-dependent protein kinase on anterior pituitary granules. Lewin MJ; Reyl-Desmars F; Ling N Proc Natl Acad Sci U S A; 1983 Nov; 80(21):6538-41. PubMed ID: 6314330 [TBL] [Abstract][Full Text] [Related]
7. Desensitization to growth hormone-releasing factor (GRF) is associated with down-regulation of GRF-binding sites. Bilezikjian LM; Seifert H; Vale W Endocrinology; 1986 May; 118(5):2045-52. PubMed ID: 3009146 [TBL] [Abstract][Full Text] [Related]
8. Cross-linking of a growth hormone releasing factor-binding protein in anterior pituitary cells. Zysk JR; Cronin MJ; Anderson JM; Thorner MO J Biol Chem; 1986 Dec; 261(36):16781-4. PubMed ID: 3023363 [TBL] [Abstract][Full Text] [Related]
10. Demonstration and characterization of the specific binding of growth hormone-releasing peptide to rat anterior pituitary and hypothalamic membranes. Sethumadhavan K; Veeraragavan K; Bowers CY Biochem Biophys Res Commun; 1991 Jul; 178(1):31-7. PubMed ID: 1712588 [TBL] [Abstract][Full Text] [Related]
11. Identification of receptor-binding pharmacophores of growth-hormone-releasing factor in rat adenopituitary. Lefrançois L; Gaudreau P Neuroendocrinology; 1994 Apr; 59(4):363-70. PubMed ID: 8202217 [TBL] [Abstract][Full Text] [Related]
12. An extremely sensitive in vitro model for elucidating structure-activity relationships of growth hormone-releasing factor analogs. Heiman ML; Nekola MV; Murphy WA; Lance VA; Coy DH Endocrinology; 1985 Jan; 116(1):410-5. PubMed ID: 2856874 [TBL] [Abstract][Full Text] [Related]
13. Human growth hormone-releasing factor (hGRF)1-29-albumin bioconjugates activate the GRF receptor on the anterior pituitary in rats: identification of CJC-1295 as a long-lasting GRF analog. Jetté L; Léger R; Thibaudeau K; Benquet C; Robitaille M; Pellerin I; Paradis V; van Wyk P; Pham K; Bridon DP Endocrinology; 2005 Jul; 146(7):3052-8. PubMed ID: 15817669 [TBL] [Abstract][Full Text] [Related]
14. Structural requirements for the activation of rat anterior pituitary adenylate cyclase by growth hormone-releasing factor (GRF): discovery of (N-Ac-Tyr1, D-Arg2)-GRF(1-29)-NH2 as a GRF antagonist on membranes. Robberecht P; Coy DH; Waelbroeck M; Heiman ML; de Neef P; Camus JC; Christophe J Endocrinology; 1985 Nov; 117(5):1759-64. PubMed ID: 2994998 [TBL] [Abstract][Full Text] [Related]
16. Administration of human pancreatic growth hormone-releasing factor (GRF) analogs enhances responsiveness of cultured rat pituitary cells to GRF. Heiman ML; Murphy WA; Nekola MV; Lance VA; Coy DH Biochem Biophys Res Commun; 1984 Oct; 124(1):217-22. PubMed ID: 6238594 [TBL] [Abstract][Full Text] [Related]
17. The effects of thyroid hormone deprivation in vivo and in vitro on growth hormone (GH) responses to human pancreatic (tumor) GH-releasing factor (1-40) by dispersed rat anterior pituitary cells. Dieguez C; Foord SM; Peters JR; Hall R; Scanlon MF Endocrinology; 1985 Mar; 116(3):1066-70. PubMed ID: 3918846 [TBL] [Abstract][Full Text] [Related]
18. Gene expression of hypothalamic somatostatin, growth hormone releasing factor, and their pituitary receptors in hypothyroidism. Tam SP; Lam KS; Srivastava G Endocrinology; 1996 Feb; 137(2):418-24. PubMed ID: 8593784 [TBL] [Abstract][Full Text] [Related]
19. Receptors for luteinizing hormone-releasing hormone (LHRH) in Dunning R3327 prostate cancers and rat anterior pituitaries after treatment with a sustained delivery system of LHRH antagonist SB-75. Srkalovic G; Bokser L; Radulovic S; Korkut E; Schally AV Endocrinology; 1990 Dec; 127(6):3052-60. PubMed ID: 2174343 [TBL] [Abstract][Full Text] [Related]
20. Proteolytic degradation of rat growth hormone-releasing factor(1-29) amide in rat pituitary and hypothalamus. Boulanger L; Lazure C; Lefrançois L; Gaudreau P Brain Res; 1993 Jul; 616(1-2):39-47. PubMed ID: 8395307 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]